See Tai Sandi

Officer · LXEO

As of 2026-09-16, See Tai Sandi has 10 Form 4 transactions on record across 1 company — 4 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $272KIndirect: $0$272Kas of 2026-09-16
  • Direct $272K
  • Indirect $0
LXEOdirect65,476 sh$272K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

LXEO · 10 trades
2025-11-18: Sale, 386 sh ($4K)2025-10-17: Sale, 3,844 sh ($34K)2025-10-17: Sale, 44 sh ($421)2025-10-15: Award / grant, 10,890 sh ($0)2025-08-18: Sale, 382 sh ($2K)2025-05-16: Sale, 367 sh ($1K)2025-03-14: Award / grant, 5,720 sh ($15K)2025-02-19: Sale, 1,486 sh ($7K)2025-01-07: Award / grant, 38,750 sh ($0)2025-01-07: Award / grant, 77,500 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-11-18LXEOSale386 @ $9.27$4K−0.6% of holding65,476Form 4
2025-10-17LXEOSale3,844 @ $8.94$34K−5.5% of holding65,906Form 4
2025-10-17LXEOSale44 @ $9.56$421−0.1% of holding65,862Form 4
2025-08-18LXEOSale382 @ $4.67$2K−0.6% of holding58,860Form 4
2025-05-16LXEOSale367 @ $2.77$1K−0.6% of holding59,242Form 4
2025-02-19LXEOSale1,486 @ $4.41$7K−2.7% of holding53,889Form 4
4 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2025-10-15LXEOAward / grant10,89069,750Form 4
2025-03-14LXEOAward / grant5,72059,609Form 4
2025-01-07LXEOAward / grant38,75055,375Form 4
2025-01-07LXEOAward / grant77,50077,500Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.